Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.
about
Cardiovascular risk factors following renal transplantThe need for tolerance in pediatric organ transplantation.Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipientsAssociation of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report.Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.Cardiovascular co-morbidity in rheumatic diseases.Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study.Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.Metabolic syndrome in patients with hematological diseases.Use of antioxidants to prevent cyclosporine a toxicity.Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS.Participant acceptability of exercise in kidney disease (PACE-KD): a feasibility study protocol in renal transplant recipients.The effects of calcineurin inhibitors on prostanoid synthesis: a randomized cross-over study in healthy humans.Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients.Association between steroid dosage and death with a functioning graft after kidney transplantation.Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant.Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER).Potential cardiovascular risk factors in paediatric renal transplant recipients.Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.Inequality in Care and Differences in Outcome Following Stroke in People With ESRDMycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?
P2860
Q26771406-6067C333-FF4B-4283-809C-1D7163AC37BEQ33637476-1DD6C67B-EAF3-40E4-A22F-6820F02D91BDQ33773992-E2BC09BF-52FE-4676-B95C-A3AE205CD898Q34294557-62834656-9B5F-46EE-ACC4-208C4FE99AFAQ36256056-B07D7910-CDB4-49D9-A6D4-315645F1DA37Q36544981-651ADEA6-B0B9-46A5-B26A-2737D499C69DQ36835851-4A1E0B36-2A7F-4671-9650-715FB02E2021Q36915663-88CDB616-A1A6-4D6D-9358-155E5C62E710Q37651129-5196FB5A-2E09-43B5-B0B2-E87F11E778FEQ37818197-CACA1974-6795-4CB3-B6AE-AB68FAA01732Q37859368-F3304309-46EB-45F9-A19A-1C0A2D70CB57Q38044776-AC47522A-0886-4607-A2E4-9674B693C1A1Q38166348-F50AA3D4-0135-4A92-B6F6-17E4FB2216A3Q38672873-025405F4-8E9C-44F0-B1E5-201254B413BDQ41627383-D3361282-BB38-45A4-9A0E-8A809A542951Q41767570-3E5C7CC2-BA66-4450-84AA-999566BF269FQ42172762-CF4030FB-D5D9-4042-BA65-2CFA9BE5DC30Q42516874-EEB58172-1083-49F2-9F30-C66D082768BEQ43485988-C8251F2C-6CE1-45B8-B79F-D2A8076C24FCQ43582235-8D101CF0-6F4A-43FA-8E2A-9F6D331055DCQ43749603-7DF20341-C091-4411-B6F1-E54FAAED7600Q43905616-D1EC8251-18EE-4D35-AC24-7E28EBAC565AQ46776593-2409929D-62CE-4F49-A394-C1CE0D038371Q48190877-59EA4707-AEB6-4BE3-8EF0-0AA82D720F70Q52888129-CDB76BC0-79BD-4A95-8CCB-1F3007B511F0Q57750156-53599A76-C56C-4FF3-94ED-6FA9AE95DD97Q57839864-090FAEBF-371D-49F4-8058-22283BAD6820
P2860
Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@ast
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@en
type
label
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@ast
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@en
prefLabel
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@ast
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@en
P2093
P1433
P1476
Effect of immunosuppressive ag ...... us on the cardiovascular risk.
@en
P2093
Johannes M M Boots
Johannes P van Hooff
Maarten H L Christiaans
P304
P356
10.2165/00003495-200464180-00004
P577
2004-01-01T00:00:00Z
P5875
P6179
1015666537